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MODERATOR WILKINSON: At a preliminary meeting, we tried to reconcile our
differences of opinion and found that, although we had many points of agree-
ment, we also had many points of disagreement. Perhaps for this reason this
particular panel was chosen.
We decided to ask each other questions, unless you have questions to ask us.
We shall start with a subject about which there has been much controversy-
the vegetable sterols. There is a difference of opinion here. I shall ask Dr. Kinsell
to tell his experience with vegetable sterols.
DR. KINSELL: We have used vegetable sterols only under experimental con-
ditions in the metabolic ward and have not made any studies of them in the
last two years. In the phase of the work in which we were trying to determine
the common denominator in the cholesterol-lowering effect of a variety of
vegetable fats, we gave huge amounts of vegetable sterols, including sitosterol,
mixed soy sterols and other forms, up to 60 Gm., which is a great deal for persons
on constant diets. In some instances, there were cholesterol-lowering effects,
presumably attributable to interference with absorption of either endogenous
or exogenous cholesterol, or both, but these effects were rarely of great magni-
tude. They were unpredictable, and for this reason, we have not continued work
in this field. '
* Conducted at the Graduate Symposium on Geriatric Medicine of the American Geri-
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MODERATOR WILKINSON: Dr. Stare, would you care to speak on this question?
DR. STARE: Noone in our laboratory has had first-hand experience with
vegetable sterols.
MODERATOR WILKINSON: Dr. Pollak?
DR. POLLAK: I should like to speak on this question, because I started this
whole business.
It is of value to try vegetable sterols. I cannot predict whether anyone will
respond or not. Some reports are favorable, others not. From the records, those
in favor have it, so far. I should like to ask whether there is anything better to
reduce the blood cholesterol level, assuming that you believe it to be desirable.
MODERATOR WILKINSON: Dr. Keys?
DR. KEYS: Our own experience is quite limited. The change usually occurs
following ingestion of a somewhat substantial amount of vegetable sterol-20 to
30 Gm. per day. There is usually a statistically significant lowering with an
average daily ingestion of 15 Gm. of mixed sitosterols. This does not seem very
interesting to us. We have stopped this work for the same reason as Dr. Kinsell.
MODERATOR WILKINSON: Dr. Epstein, have you had any experience with
this?
DR. EpSTEIN : We have had no experience.
DR. STARE: Dr. Wilkinson, may I make a statement on that? Clinicians
around Boston with whom I have talked are not enthusiastic about it. They
tend to compare it with resin therapy-a form of treatment that was occasionally
used in an attempt to lower the sodium level. You have to take 10, 12, or 15 Gm.
of this material with each meal, and also if you have a snack in the afternoon
or evening. In other words, it has to be taken every time you eat food. From
a practical standpoint and in view of the uncertainty of results and the cost of
medication, it is not practical for most patients.
MODERATOR WILKINSON: I might add that in our laboratory we tried every
method of administration from mixing it thoroughly with an artificial diet to
giving it fifteen, ten or five minutes before the meal. We also gave it in a wafer
to be taken every hour while awake.
We had difficulty securing the ingestion of more than 20 or 25 Gm. per day.
We found no predictable good results. In some people there seemed to be an
initial drop in the cholesterol level that we could not sustain. None of the de-
creases differed from the cyclic variations seen during a three-year control
period in these patients.
I agree with Dr. Stare that it is an impractical way to take medication. On
the basis of our results, we believe that not only is it impractical, but not a
justifiable way to reduce cholesterol concentration.
MODERATOR WILKINSON: Are there some questions from the audience, or shall
we talk among ourselves?
SPEAKER: I should like to ask Dr. Keys whether he believes a deficiency of
certain unsaturated essential fatty acids is as important in the pathogenesis of
atherosclerosis as an excess of saturated fats?
DR. KEYS: I know of no way in which that question can be answered, at least
not in the form in which it was posed.
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I presume that we are talking about atherogenesis and not about cholesterol.
Ai:, far as I know, there is no evidence for anything about atherogenesis in human
beings that would be pertinent to that question.
With reference to blood cholesterol concentration, we know that some of the
more unsaturated fatty acids are what might be called anticholesterol agents.
This is in the sense that they do not induce the increases in cholesterol level
that are associated with the ingestion of certain more saturated fats, but there
is by no means a regular relationship to the degree of saturation. What this
means in terms of atherogenesis in man, we do not know.
MODERATOR WILKINSON: We had agreed not to use the word "anticholesterol."
We should like to say, rather, that a hyper- or hypocholesterolemic effect is
all that has been noticed with any of these agents. It does not imply a reduction
in the endogenous manufacture of cholesterol.
Dr. Kinsell may be able to add something.
DR. KINSELL: The matter of the effect of different kinds of fats represents an
area of great interest to us, both fundamentally and clinically. However, I
should like to emphasize a statement made by other members of the panel, and
which I am sure will be made again, to the effect that in the intact human being,
unfortunately, we lack adequate means for short-term evaluation and even less
than adequate means for long-term evaluation of what takes place within a
blood vessel.
We can measure lipids and all sorts of things in the plasma. The general
working hypothesis of almost everyone in this field is that, if one has a choice
between a regimen that will produce a low cholesterol level in the blood and one
that will produce a high cholesterol level, he takes the regimen that will pro-
duce a low level and hopes that this will be good in terms of prevention or pro-
gression of the lesion. Much time and work must be devoted to the problem
before this is more than a hope.
With that as a baseline, one can say without hedging that the ingestion of a
sufficient amount of essential fatty acids (meaning fatty acids of the linoleic or
arachidonic acid series, the doubly and quadruply unsaturated fatty acids)
under appropriate circumstances will be associated with a decrease in the con-
centration of blood cholesterol. Moreover, if given in sufficient amount and with
appropriate other features in the diet, the decrease in the cholesterol level will
be profound. We first noted this in 1951 and have had ample evidence of it since.
It has been confirmed by many people. The mechanism is still unclear.
One of the important things for all of us to keep in mind is that cholesterol,
which on occasion has been regarded as a very bad "boogy man," is found
wherever there is animal life, and as such it undoubtedly has an important
physiologic role. Therefore, when approaching this problem, one of the big jobs
is not to determine how to get rid of cholesterol, but to determine the normal
role of cholesterol and the rules of the game. Then we shall know what to do
about the favorable modification of abnormal situations or, better still, the
prevention of abnormal situations.
In a chemical sense, there are 3 major lipid materials in the blood. There are
other lipids, too, but we shall talk only about these 3. The first is triglyceride,
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the glycerol molecule with 3 molecules of fatty acid attached. As far as we know,
the make-up of the triglycerides probably varies under normal conditions and
bears a significant relationship to the particular diet that is being consumed.
Our working hypothesis is as follows: Triglyceride probably serves as the
major source of fuel that keeps the body running throughout the twenty-four
hours. This means, then, that a great deal of fatty acid has to be moved around
and that the transport of fatty acid is a high-priority situation. Therefore, in an
economy noted for overlapping in terms of safety factors, there will be several
ways of doing the same thing. The phospholipids also are part of the transport
system for fatty acids. For reasons that we do not understand well as yet, one
of these fatty acids normally is probably an essential fatty acid.
To run smoothly, the phospholipid must have one essential fatty acid and one
nonessential fatty acid. It is the nonessential fatty acid that is constantly being
burned and replaced. The essential fatty acid may well be associated with the
way the phospholipid fits into certain enzyme systems. As the phospholipids are
constantly being broken down and replaced, there has to be a refurbishing of
the essential fatty acids, and possibly this is where cholesterol esters are intro-
duced.
This means, then, that the essential fatty acids are just what the name implies.
They are vitamins, i.e., they are things that you either get in your diet or you
don't get at all, because you cannot make them from other sources. The more
saturated acids can be made from the less saturated acids but, once things get
below the stage of linoleic acid, nothing can be made above that level. As you
know, linoleic has two double bonds.
Since fat and water do not mix, and since fatty acid and these other lipids
have to travel around in an essentially aqueous medium, there must be a variety
of vehicles to prevent the formation of clumps of fat and consequent fat embo-
lism. The main job of the lipoproteins is to make fat soluble.
MODERATOR WILKINSON: In fairness to our audience, we might point out
that when Dr. Kinsell uses the word "essential," it does not imply unanimity of
opinion among the investigators in the field. The amount of fat-soluble vitamins
is smaller than the amount of fatty acid, saturated or unsaturated, that we are
discussing. I do not mean to criticize the term "essential," but I want to point
out that many people would prefer to use saturated versus unsaturated rather
than essential versus nonessential.
I should like to ask Dr. Stare to talk about this question as he is the only man
I know who is illogical enough to cure xanthoma by intravenous feeding of fat.
Da, STARE: Dr. Kinsell used the phrase "under appropriate conditions." This
is an important phrase. Under such conditions, one can reduce the serum cho-
lesterollevel. These appropriate conditions are, tube feeding, which Dr. Kinsell
frequently uses, or formula diets. Formula diets do not consist of meat, potatoes
and string beans; they are mixtures of corn oil, sucrose and skimmed-milk
powder. Three leaders in that field have been Kinsell, Bevredge in Canada, and
Ahrens at the Hospital of the Rockefeller Institute. Under these "appropriate
conditions"-the incorporation of large amounts of oil with an unsaturated
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fatty acid-it is possible to reduce the concentration of serum cholesterol.
Dr. Kinsell has now approached more realistic conditions, in that he has a
modified feeding formula; that is, he has a certain type of breakfast and lit certain
regimented feod program. The point I am leading up to is that I know of no
evidence which indicates that an appreciable lowering of cholesterol concentra-
tion will result if we substitute rather generous amounts of corn or cottonseed
oil fer the usual amounts of butter, margarine, peanut butter, animal fat or
mayonnaise, as an accompaniment of our customary diet of meat, beans, potatoes
and grapefruit.
From an experimental point of view, here are some positive results. As Dr.
Kinsell showed us this morning, it has been possible in some patients to reduce
cholesterol concentration from around 400 mg. to about 270 mg. per 100 cc. In
1 patient, the value was around 260 mg. per 100 cc., and that is quite a reduc-
tion. However, I know of no evidence to indicate that, if you add these oils to
an ordinary diet in any reasonable quantity, the same thing will take place.
MODERATOR WILKINSON: Is there another question from the audience at this
point?
DR. JOLLIFFE: I should like to ask the panel whether there is any way to make
a plasticized fat from corn oil, as is done in industry, without destroying its
effect in lowering the blood cholesterol level. I know that a fat can be plasticized
and remain unsaturated, but can it be plasticized without destroying its effect
on the serum cholesterol level?
MODERATOR WILKINSON: I take that to mean, can one hydrogenate up to a
point where it is a white fat and not a liquid one. Is that correct?
DR. JOLLIFFE: No. Do you have the cis forms and the trans forms, or can you
leave the unsaturated bonds in these fatty acids, plasticize them, ana have them
remain almost as unsaturated as before? I have seen no evidence that these fats
do not continue to elevate the serum cholesterol level, just as though they were
hydrogenated.
MODERATOR WILKINSON: Dr. Stare, would you like to answer that?
DR. STARE: I obviously do not know much about it because I do not under-
stand the term plasticize. The only thing I can say is that I have been told by
manufacturers of shortening that they can control the degree of hydrogenation.
Little is known about whether or not the isomers that are formed during hydro-
genation affect the cholesterol content. As far as I know, the matter has to be
limited largely to a discussion of the effect of linoleic acid, much less that of
arachidonic acid. There are a few unpublished studies that show that the isomers
formed in this reaction have no effect. Dr. Keys mentioned these to me, and
perhaps he should tell you about them.
DR. KEYS: I would not want to say much about that question. This is a
popular subject to talk about on the basis of no knowledge at all. 'I'e my knowl-
edge, at present at least, no one has published or publicly produced evidence
that there is any difference whatsoever in the effects of the cis and the trans
forms. That can be stated flatly. Perhaps theoretically cis is better than trans
or vice versa, if you happen to like those configurations but there is no evidence
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as yet that these differences are biologically reflected in man. We want to in-
vestigate that problem.
I am interested, however, in the question as to whether we are talking about
linoleic acid or unsaturation, because they are not necessarily the same thing.
Some natural food fats contain considerable linoleic acid. Others have little and
may still be more unsaturated than the first. Corn oil is an example of an un-
saturated fat that has a fairly large amount of linoleic acid in it. We have made
comparisons under rigidly controlled conditions. In the same subjects the regimen
was changed from corn oil to sunflower-seed oil (which contains more linoleic
acid and is much more unsaturated), or from corn oil to sardine oil (which con-
tains no linoleic acid and little arachidonic acid, but is extremely unsaturated).
Under controlled conditions, we invariably found that a change from corn oil
to one of these fats caused a rise in the average serum cholesterol level. When
people maintained on these fats change to corn oil, the cholesterol level falls.
MODERATOR WILKINSON: Dr. Kinsell, will you tell us what your experience
has been?
DR. KINSELL: Going back to the matter of the term "unsaturated" versus
"essential"-I personally do not use the term "essential" with any intent to
indicate that we must have a pound of this a day, but rather to indicate that
it is something which by definition one does not synthesize from other sources.
You get it from your food, or you do not get it. It is different from oleic acid,
for example, which is a single-bond acid that can be made from all sorts of
things, but which is not in the "essential" category. Then there are other satu-
rated or unsaturated substances which we know little about, as some of the other
panelists have indicated, and which may not have the same effects as linoleic or
arachidonic acid. This is an area where much work remains to be done.
As for relating the effects of an oil or a fat to its content of this so-called
essential fat-specifically, linoleic acid-over the years we have carried out
studies with safflower-seed oil, cottonseed oil, soybean oil, corn oil and a great
variety of oils, and have found that safflower-seed oil per unit of volume will
do more than will an equal volume or weight of corn oil. Roughly, this difference
in effect is related to the difference in linoleic-acid content.
Recently, we carried out studies with ethyl esters of the fatty acid, that is,
compounds with an ethyl radical attached to a simple fatty acid and free, or
nearly free, of all other contaminants. In 1 instance, a batch of material of a
very high degree of purity produced the same type of change. As far as the data
go, these changes appear to be related to the amount of linoleic acid. This
probably does not mean that there are not other things in oils which are of
importance. In view of all of the interest in essential fatty acids and so forth,
I should like to warn against any undue enthusiasm. You will recall that not
long ago cholesterol was regarded as a poison to be kept out of the diet at any
cost.
We do not wish to have anyone believe that we think that essential fatty acid
is the entire answer to the problem of atherosclerosis or to lipid metabolism.
That it is an important phase is beyond question.
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MODERATOR WILKINSON: I might point out that there is relatively little
linoleic acid in mother's milk. Is that not correct?
DR. KINSELL: It is correct that the amount varies with the intake.
MODERATOR WILKINSON: Dr. Keys.
DR. KEYS: In our comparison of 3 fats under rigidly controlled conditions and
with metabolic balances, we observed changes in the concentration of serum
cholesterol in 26 men. The differences between the levels in the groups fed corn
oil, sardine oil and sunflower-seed oil were significant statistically, but whether
they were biologically important or not is something else. When the corn oil in
a diet was changed to the same amount of sardine oil, the serum cholesterol level
rose. In terms of the degree of saturation, sardine oil is much more unsaturated
(with a number of 186 in this particular case) than corn oil (with a number
of 120).
Similarly, with sunflower-seed oil (our particular batch runs 61 per cent
linoleic acid and has the number 140 or 141)-the cholesterol level rose in asso-
ciation with the increase in the intake of linoleic acid and fell with the decrease
in intake which occurred in changing from sunflower-seed oil to corn oil.
In experiments with safflower-seed oil (78 per cent linoleic acid) we obtained
similar results. If we replaced corn oil with safflower-seed oil, the cholesterol
level did not fall. We have done this in both directions.
MODERATOR WILKINSON: I should like to point out that these changes are
significant in the statistical sense but, at least as far as the moderator is con-
cerned, they have little significance in the clinical sense.
DR. STARE: It might also be pointed out that the changes Dr. Keys men-
tioned took place in some 20 people when they were eating meat, potatoes, string
beans and grapefruit. He could have shown, as Dr. Kinsell has shown for some
years, that if you incorporate these oils into formula diets, or into tube-feeding
diets, the changes are much more profound.
DR. KEYS: These diets involve 100 Gm. of experimental fat per day.
MODERATOR WILKINSON: Is there another question from the audience?
DR. KINSELL: With regard to Dr. Wilkinson's statement, may I say again
that we would not regard the magnitude of these changes as being significant
in a biologic sense.
DR. NATHANSON (from audience): I am a bit flustered. We have had a dis-
cussion of acids, and to me it seems that we are discussing something that is
present. I, and maybe others, should like to know the opinions of the panelists
as to what causes this hypercholesterolemia. We think of androgens and the
metabolic activities in the various tissues of the body. However, it would interest
us more to have a discussion of the biochemistry of lipid metabolism. I have a
certain concept, which may not be totally accepted. I believe that altered lipid
metabolism is based upon altered carbohydrate metabolism. As for the bio-
chemistry-in the degradation involved in the transport system and the break-
down of lipids, eventually these compounds have to enter the acetoacetic-acid
cycle. In the oxidative phase, there may be some alteration or delay, which
accounts for the increased cholesterol content in the blood.
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Another point that strikes me is the blanket use of the word cholesterol. Are
we to disregard the S, theory, the S,-1020, and so forth?
MODERATOR WILKINSON: Yes, I think that we can disregard it.
DR. NATHANSl!)N: We have been taught that theory so long that I should like
to know the opinion of the panel today and to have some discussion concerning
the chemical basis for hypercholesterolemia, so that we may plan an attack that
way.
MODERATOR WILKINSON: I think Dr. Epstein can give us at least one basis
for a high versus a low blood cholesterol level. Dr. Epstein.
DR. EpSTEIN: I think I can give at least one reason why serum cholesterol
levels may become elevated and one reason why this would seem undesirable.
May I also say a few words about atherosclerosis in general because it is this
disease primarily rather than the serum cholesterol level, which we wish to con-
trol. The concentration of serum cholesterol is determined by multiple factors
and so is atherosclerotic disease. In fact, all diseases, including the infectious
ones, have multiple causes. As Dudley pointed out twenty years ago, these
causes may vary in relative importance, according to space and time. This epi-
demiologic viewpoint is distinctly relevant to the current discussion. Our ap-
proach to this problem depends on the kind of population and the levels of
dietary intake. I am convinced that if one compares populations that differ
widely with regard to fat intake (and possibly in other dietary constituents),
they will also differ widely with regard to serum cholesterol levels. The most
important single determinant of the amount of atherosclerosis found in such a
population may be the quantity of dietary fat. This is Dr. Key's basic theory.
To my mind, this is established.
The difficulty comes when we consider a country like the United States where,
in general, everybody eats a high fat diet, has a fairly high blood cholesterol
level, and has a considerable amount of atherosclerosis. Yet there is good evi-
dence that, within this country, there are marked differences in the frequency
of atherosclerosis and probably even differences in blood lipid levels among
different population groups. The question arises whether factors other than lipid
levels and diet come into play in these situations. In a study we carried out in
New York City among clothing workers of Italian and Jewish extraction, we
found that Jews had twice as much coronary heart disease, even though their
diet differed relatively little from that of the Italians. We were also able to show
that this could not be explained solely in terms of the lipid levels among these
two groups; other population groups may behave differently.
In this context, it would seem important to decide upon one's aim, when con-
sidering dietary or other kind of management of lipid levels. It is becoming
obvious that one can change these levels in a number of different ways, more or
less successfully-but what magnitude of change would be necessary to affect
the prevalence of atherosclerosis?
Let us take 2 population groups, one of which has an average serum cho-
lesterol level of 230 mg., and the other a level of 200 mg. per 100 cc. It is fair
to say that people with serum cholesterol levels habitually below 200 mg. per cc.
do not have atherosclerosis as often as people with serum cholesterol levels
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above 200 mg. It is also fair to say that American populations in general have
mean serum cholesterol levels around 230 or 240 mg. per 100 cc. If we assume a
standard deviation of 30 mg. per 100 cc., it is obvious that in the population in
which the mean level is 230 mg., only 16 per cent of the population will have levels
below 200 mg. Consequently, a large proportion (84 per cent) of the population
will have potentially atherogenic levels. In a population in which the mean level
is 200 mg., as much as half the population will have serum cholesterol levels
below 200 mg. Thus, if the concentration of serum cholesterol were the only
important determining factor, one might on that basis alone expect a profound
difference in the prevalence of coronary heart disease among these 2 population
groups whose serum cholesterol levels differ by only 30 mg. per 100 cc. This is
the order of magnitude of the change that might be achieved by lowering the
dietary fat intake.
Among American population segments whose mean serum cholesterol levels
are between 230 and 240 mg. per 100 cc., it may be assumed that a change of
30 mg., or something of that order, will cause appreciable alteration in the
prevalence of coronary heart disease. Future epidemiologic studies will solve
this particular problem, rather than acute dietary experiments.
MODERATOR WILKINSON: I might summarize this, and then call upon Dr.
Stare. It is more or less the consensus of the panel that in discussing changes in
blood lipids, the alpha and beta lipoproteins and the concentration of beta-
lipoproteins furnished by the Sf values, we are concerned with laboratory theo-
retic desirable or undesirable changes which will produce atherosclerosis if a diet
or a regimen is modified to a considerable degree. Dr. Stare.
DR. STARE: In order to try to answer or comment on Dr. Nathanson's ques-
tion, I have jotted down a few things which seem to be involved in the causation
of atherosclerosis.
There are, certainly, genetic factors. I do not know what we can do about
them except to recognize their existence. It has been well established that certain
body types favor the development of coronary artery disease. It probably makes
little difference how much atherosclerosis one has as long as he does not get a
cerebral or coronary thrombosis. The structure of blood vessels has something
to do with the development of plaques. As far as I know, this is something that
may be on a genetic basis and we cannot do much about it. Let us say, therefore,
that genetic factors are involved in this disease, as they probably are in many
diseases.
Secondly, estrogens are involved. It has been shown that the level of circulating
lipids in the blood stream can be influenced by estrogen therapy. Everyone is
well aware that this disease is far more prevalent in the male than in the female,
until five or ten years after the menopause when the incidence in the female
increases. Experimentally, there are differences among animals. In many cases,
the human sex difference is reversed. The female rabbit and the female rat are
more susceptible to the experimental production of atherosclerosis than the
male. Therefore, estrogens must have something to do with the things that we
measure in the blood which supposedly are related to this disease.
The third is diet. Experimentally, half a dozen or more nutrients have been
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shown to bear a relationship to the development of atherosclerosis. There also is
the question of calories-not only the source, but the amount of calories, because
of changes in body weight. In the field of nutrients, fat is being experimented
with far more than other nutrients. However, I should like to mention a few of
the others that have been studied experimentally.
In our laboratory, we have shown that diets high in sucrose favor the reten-
tion of cholesterol in the rat. In other words, there is not only the question of
where the cholesterol is coming from and how much is coming, but how much
cholesterol is being eliminated. We get rid of cholesterol by the excretion of bile
acids. Dr. Portman in our laboratory showed two or three years ago that when
the source of carbohydrate in rat diets was changed from sucrose to starch, the
animals excreted more bile and got rid of more cholesterol during periods of high
starch diets than during periods of high sucrose diets.
One of the usual differences between the diets of primitive groups of people,
among whom this disease is relatively rare, and the diets of Americans is the
source of carbohydrate. Primitive peoples tend to live off roots. Root vegetables
furnish a diet high in starch and low in sucrose. American diets tend to be high
in sucrose and lower in starch.
Pyridoxine came into the picture from the original or early studies wherein
the late Dr. Reinhart produced a type of arteriosclerosis in monkeys with pyri-
doxine deficiency. The biochemists have shown that the conversion of linoleic
acid to arachidonic acid requires pyridoxine.
In some unpublished studies that my colleague Dr. Waddell has been making
at the Massachusetts General Hospital with substantial numbers of people
(50 or 60), it was found that administration of huge doses of pyridoxine (about
100 mg. three times a day) caused a marked lowering in the serum cholesterol
level. To some extent, this is similar to the report published a few months ago
from the Mayo Clinic. They reported the same thing with the use of tremendous
amounts of niacin.
Protein metabolism is clearly implicated in the development of atherosclerosis
in the experimental animal. We have shown it in the monkey-an animal sus-
ceptible to increases in blood cholesterol concentration. If the protein in the diet
of the monkey is what is called an "alpha-protein" (derived from soybeans)
which is low in organic sulphur, methionine and cystine, and these sulphur com-
pounds are added to the diet, the serum cholesterol level either is not raised or
it tends to go down. We have shown the same thing in rats, as published a month
ago in the Journal of Experimental Medicine. However, these observations on
protein in 2 species of experimental animals are not in accord with the observa-
tions in man.
In this country, where we have a great deal of coronary artery disease and
atherosclerosis, we tend to have an abundance of good-quality protein in our
diet. On the other hand, the people of South Africa, Guatemala, Nigeria, Italy
and other places, who have a low incidence of this disease, generally have a far
lower intake of protein than we do, and it tends to be more from vegetable
sources than animal sources as compared with our diet.
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Another thing that might be emphasized is that the production of infarction
in experimental animals is rare. There are all kinds of reports about the experi-
mental production of atherosclerosis, but relatively few about the production of
infarction. In 3 or 4 reports in the literature, the authors claim to have found
extensive infarcts in a few of their animals. In our paper in the current issue of
the Journal of Experimental Medicine, we referred to 1 animal in which there
was an extensive infarct; 1 animal among 50 or 60 is not many. I mention this
in order to point out that one of the deficiencies of animal studies today is the
lack of a procedure or technic to cause infarction.
We have shown in some acute studies in a few people that gaining or losing
body weight is a factor that has something to do with the regulation of cholesterol
metabolism. Dr. Keys, on the other hand, has shown in nonacute studies with
large numbers of people that exercise is a relatively minor matter in regulating
cholesterol metabolism. We both agree that it is a factor.
We end up with the fact that atherosclerosis is an important disease, partic-
ularly to the American public and to American males. It is a disease subject to
experimental attack. It is being attacked, and there have been some advances in
the last few years. Involved are the factors of genetics, sex hormones, and diet. An
interesting question to ask is whether or not this disease can be prevented. The
answer is yes, it can be prevented. What is the evidence? The evidence is the
fact that there are millions of people in this world that do not have this disease,
which means that it must be preventable!
MODERATOR WILKINSON: Are there any further questions from the floor?
SPEAKER: My question is, what about the thyroid? I should have included
that when I mentioned estrogens.
DR. STARE: I should have said that the thyroid hormone has something to do
with this, because you can affect the circulating lipid level by the administration
of thyroxine, and the level tends to be high in people with hypothyroidism.
Experimentally, you can also affect it to a slight degree by administering thyroid
hormone.
MODERATOR WILKINSON: Thyroid is wonderful for conditions in which there
is a lack of normal hormones. No good clinical evidence has been presented to
show that an excess of thyroid is beneficial. Dr. Kinsell, would you like to speak
on that?
DR. KINSELL: There is evidence that pharmacologic amounts of thyroid, or
related material, will under appropriate circumstances produce a fall in the con-
centration of blood cholesterol, but I do not think that this is in any way syn-
onymous with the thought that it is a good therapeutic measure, particularly
in the group of people who have poor circulatory status initially. If one super-
imposes an iatrogenic hyperthyroidism, the cure is potentially worse than the
disease.
MODERATOR WILKINSON: In 1947 or 1948 at the University of Michigan, we
carried out an experiment wherein 6 people, one of whom was myself, became
toxic on exogenous thyroid but maintained a normal weight. In none of the 6
persons studied was there a fall in blood cholesterol concentration.
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My laboratory has also reported cases of hypercholesterolemia of the familial
type, in which there was clinical hyperthyroidism showing no relation to the
level of the blood cholesterol. It is true that if a person becomes very thyrotoxic
and loses a great deal of weight, the cholesterol level will fall a little.
SPEAKER: I should like to hear the panelists discuss the statistics on blood
cholesterol a bit more. For instance, Dr. Epstein noted that at levels of 230 and
200 mg. per 100 cc. or slightly below, there is a statistical difference between 2
population groups. If the difference, say, amounts only to a ratio of 1:2, that
may be 100 per cent. What is the relationship when there is a difference of 400
per cent or 1000 per cent-as in Italy where the death rate from coronary artery
disease is about one-fourth of ours, or as in Japan where the death rate is only
one-tenth of ours. I should like to know more about the situation where there is
a different relationship.
MODERATOR WILKINSON: Dr. Epstein, would you like to take that?
DR. EpSTEIN: If there were some way to reduce blood cholesterol levels in this
country to the levels that are found, say, in Japan or in various other countries
with a low incidence of atherosclerosis, the prevalence of atherosclerotic disease
could probably be markedly lowered. As a matter of fact, looking at the data
from the cooperative study on lipoproteins, it is evident that there is a marked
difference in disease incidence between groups having high and low cholesterol
levels. The only trouble in this country is that so few people have low levels.
I think that if there were some way to lower blood cholesterol levels signifi-
cantly, it would make a striking difference.
DR. POLLAK: There is really no parallelism between high cholesterol levels
and atherosclerosis. Let's not fool ourselves. We overemphasize the blood cho-
lesterollevel. There is a correlation in familial hypercholesterolemia-a condition
in which there is a high. incidence of atherosclerosis and complications of the
disease, namely, coronary occlusions in young people. By and large, however,
the correlation is not clear-cut.
I was happy that Dr. Stare brought up the question of other nutrients and
pointed out not only the importance of quantity, but of quality. He mentioned
unsaturated fatty acids, methionine, pyridoxine, and so on. I do not believe
that everybody in this audience has a lack of unsaturated fatty acids, plant
sterols, pyridoxine, nicotinic acid, tocopherol, or methionine. Still, almost every
one of us has a considerable degree of atherogenesis, i.e., plaques, in some of our
arteries, and some of us here may have had a complication such as infarction.
Maybe it is not only what we do not eat, but what we eat too much of, that
matters. The ratio between unsaturated and saturated fatty acids in our diet
may be wrong. A surplus of certain fatty acids may be just as bad as a lack of
unsaturated fatty acids.
When we speak of the different factors causing atherosclerosis, we should not
overlook the probability that this is not a disease of blood lipids and blood vessels
alone, but a disease of the whole body. When a correlation is attempted, it be-
comes evident that there is an increase of clinically manifest atherosclerosis
June 1958 LIPID METABOLISM IN CARDIOVASCULAR DISEASE 463
with increasing age. There is enzymatic deficiency in aging, and there is liver
dysfunction in aging. These may be within what we call physiologic limits, but
possibly contributory to the deposit of lipids.
I am not sure that we should attempt to decrease blood cholesterol concen-
tration. Maybe we can prevent the deposition of cholesterol in some other way.
Maybe stabilization with albumin, phospholipids, or SH-compounds will provide
the answer. It has been shown in experimental animals that the precipitation of
lipoprotein molecules can be prevented.
MODERATOR WILKINSON: Dr. Stare has an engagement and must leave at a
certain time so I should like to give him a chance to comment at this time.
DR. STARE: Some of our data which have not as yet been published, but which
were recently accepted for publication in the American Journal of Medicine, show
that there is a distinct difference between the cholesterol levels of young males
who have infarctions and those who do not have infarctions. My comment on
the question that someone raised about the effects of the cholesterol level is that
I firmly believe that the level of serum total cholesterol does furnish a measure-
ment of the degree of atherosclerosis. The reason is this: atherosclerosis has been
produced experimentally in 6 or 7 species, including the monkey. The only way
it has ever been produced is through some mechanism for elevating the concen-
tration of serum lipids, including cholesterol. In the rat studies that we report
this month in the Journal of Experimental Medicine, the cholesterol levels were
in the range of 1000 mg. per 100 cc.-tremendous concentrations that we worked
out by a dietary technic to produce atherosclerosis. Why? Because we wanted to
do something in the hope that we could produce atherosclerosis. At such concen-
trations, there is no correlation between the degree of atherosclerosis and the
serum cholesterol level, but we are working with levels of 800, 1000 and 1500 mg.
per 100 ce.
We have found during the last year or so, in studies that are not yet published,
that when we work at much lower cholesterollevels-150, 200 and 225 mg. per
100 cc. (modest elevations compared to the normal range in the rat of 70 to 90
mg. per 100 cc.)-there is clear-cut correlation between the degree of hypercho-
lesterolemia and the extent of the atherosclerotic lesion at necropsy.
I am sure that others have published similar data, so I would say almost
without a shadow of a doubt that measurement of the serum total cholesterol
level today is the most important single laboratory determination we have for
use in trying to evaluate whether a person has, or is developing atherosclerosis.
DR. POLLAK: Would you qualify that and say especially in the lower age group
and much less in the older age group?
DR. STARE: Yes, I would.
MODERATOR WILKINSON: It is fair to point out that when Dr. Stare tends to
say that this is an index of atherosclerosis, he does not mean in the patient sitting
across the table from him. If you choose almost any level of blood cholesterol,
or Sf molecules, or blood rhubarb, whichever you want to take, you will find
that false positives will far exceed the cases you diagnose correctly.
464 PANEL DISCUSSION Vol. VI
It is pertinent to mention the long-term studies of Patterson and his group in
Western Ontario. They did not find a correlation between the level of blood
cholesterol and the degree of atherosclerosis present at necropsy.
It is also of interest that in young persons the average values for blood cho-
lesterol concentration frequently include extremely high levels-as in xanthoma
patients, who are much more likely to get atherosclerosis than the person with
a modest elevation of cholesterol. Dr. Keys, you probably would like to say
something here.
DR. KEYS: I am not quite sure whether we are agreeing or disagreeing about
something, and whether this is what the audience wants us .to discuss. I agree
with Dr. Stare that at present most of us .in the field think that determination
of the blood cholesterol concentration is the best single measure we now have.
If this measurement is carried out in large numbers of people, it can help us to
make much better guesses regarding prognosis, as a statistical proposition. At
the same time, I emphasize that we cannot make an accurate prognosis or diag-
nosis with any of these measurements at present.
One difficulty that should be stressed again and again is that we, the American
public today, are in general a hypercholesterolemic population already afflicted
with atherosclerosis. To try to decide which person will be the first to show clinical
consequences of this basic fault is rather a foolish proposition, I believe.
MODERATOR WILKINSON: Dr. Kinsell?
DR. KINSELL: Amen, to the last comment and to most of those that preceded
it. In masses, fine; but in individuals, we have no "Wassermann" that tells who
is going to have a coronary thrombosis or when. May I now or later say some-
thing about estrogen?
MODERATOR WILKINSON: At this point, it might be wise to hold that to see
if we have a question from the floor.
SPEAKER: As a practicing physician interested in keeping well, I should like
to ask whether or not there is any value in such things as choline, methionine and
so forth. These drugs are supposed to, and sometimes appear to, reduce the
cholesterol level.
The second question is whether or not you can give us anything about the use
of iodine in this connection.
MODERATOR WILKINSON: I shall call on the panelists in rotation for this, and
take the prerogative of the moderator to say that in my laboratory we do not
find choline, methionine or various mixtures of these to be effective. We see no
logical reason for their use. We have not used iodides. Dr. Kinsell?
DR. KINSELL: My experience is the same as regards choline and the methionine
group. As for the iodides, we have used them but have no idea how to evaluate
them. It is our clinical impression that possibly there may be something interest-
ing in this field that warrants careful investigation.
MODERATOR WILKINSON: Dr. Keys?
DR. KEYS: With regard to choline, methionine, and the like, we have observed
no effect whatsoever in human beings with any of these drugs in their regular
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form or with any of the preparations offered to us by pharmaceutical houses.
We have not used iodine.
MODERATOR WILKINSON: Dr. Pollak?
DR. POLLAK: Some of these drugs-for instance, iodine-are mild vasodilators.
Many aging people have fatty livers, and since the lipotropic substances remove
neutral fat (not cholesterol) they may improve liver function and patients may
feel better. I don't see much harm, nor any real good, as far as atherosclerosis is
concerned. It may be like taking a stimulant.
MODERATOR WILKINSON: Dr. Stare?
DR. STARE: I would not add to any of the comments that have been made.
I agree with them.
MODERATOR WILKINSON: Dr. Epstein?
DR. EpSTEIN: No further comment.
MODERATOR WILKINSON: Is there another question from the floor?
SPEAKER: I was interested in what Dr. Pollak said about enzymes. I wonder
if a possible reason for an elevated serum cholesterol level might be a deficiency
of the enzymes that ordinarily would make the precursors of cholesterol form
some more useful compound, but when present in insufficient supply would
permit these precursors to turn into cholesterol.
DR. POLLAK: That is my way of thinking about the whole thing. I think that
basically there may be a deficiency of some enzyme. I have been hunting for
that enzyme (cholesterase) for about fourteen years and I have not yet found it.
MODERATOR WILKINSON: Are there any other questions from the audience?
SPEAKER: I should like to ask the panelists if they know of any work that
has been done, or if they have any ideas regarding the effects of environmental
factors and perhaps endocrines on the level of cholesterol.
MODERATOR WILKINSON: I am not sure that we understood that, sir. Will
you repeat it, please?
SPEAKER: I referred to the effect of strain. Has any work been done to show
its effect on cholesterol concentration?
MODERATOR WILKINSON: I think Dr. Keys has a study in progress. I do not
know whether he is ready to report on stress and strain at this point, but we
shall ask him.
DR. KEYS: As you know, Dr. Wilkinson, some of us have been trying to get at
this question of stress and strain for a long time. We have brought psychiatrists,
psychosomatists, psychologists, and sociologists in to work with us. The net
result is a big zero-mainly, I think, because of lack of good methods. We have
no way of measuring it. Thus, the answer is simply that we know nothing about
the question of stress and strain. It is unmeasured and unmeasurable at present.
We can say that if modern civilization, telephones, radios, and being run over
by automobiles be stressful, we can find plenty of places where these things
happen and yet the residents do not have much coronary heart disease. We can
also find places where these environmental factors are not operating (as I found
last summer and early fall in Finland, a country in which people live simply and
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perform much hard physical labor) but where the frequency of coronary heart
disease is at least as high as in this country. Therefore, I would Bayat present
that there is no evidence to support the idea that there is a relationship between
stress and atherosclerosis, and that on the other hand, there is no definite evi-
dence against it. We are talking in a vacuum most of the time.
MODERATOR WILKINSON: We might at this point ask Dr. Keys whether or not,
in Finland, the suicide rate is as high as generally reported throughout the
Scandinavian countries. If it is, this might indicate some stress not measured by
the simple life.
DR. KEYS: Dr. Wilkinson, we have tried to use various things such as suicide
rates and the frequency of diagnosis of neurosis and psychosis, and have found
no relationship. Everybody says those things do not have to do with stress and
strain.
The highest suicide rate in the world at present is reported to be in Japan,
followed by Denmark. What that means, I do not know.
MODERATOR WILKINSON: Are there any other questions?
SPEAKER: My question is about a specific product-Cytellin of Lilly. Can you
tell me its value? How does it work, and does it effectively control the level of
cholesterol?
MODERATOR WILKINSON: We discussed this question in opening the panel. We
thought it better not to name specific products, but we have covered all of the
vegetable sterols in rather meager fashion. I think no member of the panel really
recommends or uses the material. If I am wrong, I should like the panelists to
speak up.
DR. KEYS: Dr. Wilkinson, could we add the point that some of the vegetable
sterols, in contradiction to the statements in textbooks, are absorbed and some
of them do not appear as cholesterol in the ordinary measurement. Thus, one
may have a false sense of security through having a low blood level of cholesterol
but a high level of plant sterols. Finally, there is evidence that these materials
can appear in the atherosclerotic lesion. Therefore, I do not see where we are
getting with this question.
MODERATOR WILKINSON: We might also point out that a week ago last Sunday
it was reported by one of the groups at Goldwater Hospital that it is possible to
have dihydrocholesterol gallstones in animals fed these substances. Gallstones
have not been produced by sitosterol, as far as I know, but by similar substances.
I think the subject is far more complex than we have time to go into now, but I
do not believe that many laboratories are still enthusiastic about the use of these
vegetable sterols. Dr. Pollak, do you want to add something?
DR. POLLAK: The only thing I would like to say is that Cytellin is a sitosterol
product. You spoke of the necessity for large doses. If the fat in the diet were
restricted to, let us say, 50 per cent and combined with a smaller (50 per cent)
dose of sitosterol, perhaps a compromise could be made.
In the first set of patients I reported, I mentioned a case of gallstones in dis-
cussion. We do not always have one specific drug for any disease. If nothing else
helps to reduce the blood cholesterol level, maybe sitosterol will. It is a question
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of trying. If it works, it is all right; if it doesn't, nothing has been lost. As we
have seen today, we have nothing much better to offer. Essential fatty acids
work in some patients and in others they do not. Nicotinic acid and pyridoxine
go down the same drain.
MODERATOR WILKINSON: Have you actually seen sitosterol work in a patient
still taking the drug? That is more or less the sense of the question.
Has any of us given his patients sitosterol or the vegetable sterols other than
during experimental periods? Is that the question you wanted answered?
SPEAKER: Yes, that is right. I saw it work effectively in hypercholesterolemia,
but its effect is wearing off. I wondered if that was your experience, or whether
it is a matter of the diet?
MODERATOR WILKINSON: We have had no good results, so we do not use
sitosterol, in our laboratory any more. Dr. Pollak, how long has any of your pa-
tients been taking sitosterol?
DR. POLLAK: The longest is eighteen months.
MODERATOR WILKINSON: Is he still receiving it?
DR. POLLAK: No. I discontinued it. I am not convinced that we have to reduce
the blood cholesterol level. Dr. Stare spoke of elevated blood cholesterol levels
in younger people with infarction; but what are we trying to diagnose, infarction
or atherosclerosis? Some of you may have read 2 papers of mine published not
long ago in the Journal of the American Geriatrics Society, in which I raised that
question. Are we justified in dividing people into goats and sheep according to
whether they have had a coronary infarction or not?
MODERATOR WILKINSON: Someone had a question.
SPEAKER: Do the panelists know whether the young Oriental who comes to
America and eats an American type of diet has atherosclerosis in later life?
MODERATOR WILKINSON: Dr. Kinsell, you see many young Orientals.
DR. KINSELL: We have quite a few data on young Orientals, most of them
second generation. We also have a few data on fairly young Orientals who have
recently come to this country and consume something approaching our diet-
not identical, because they do not like our diet. There is a significant change in
their plasma lipid levels, particularly with reference to cholesterol.
SPEAKER: Thank you.
DR. KEYS: With regard to the Japanese at least, it is evident that a major
difference exists between the Japanese in Japan and their relatives from the same
part of Japan living in the Hawaiian Islands. During the last two months, we
have been able to carry out a cholesterol study on Japanese living in Los Angeles,
although there we do not have the necropsy material that we had in Japan and
Hawaii.
The average cholesterol concentration for 52 men selected as representative
of the business class was compared with that for a Caucasian group at the same
time. The 52 Japanese, aged 40 to 49 years, had an average serum cholesterol
level of 246.2 mg. per 100 cc. In that community, according to the vital statistics
and the records of the Japanese Hospital in Los Angeles, coronary heart disease
is the most important and most frequent single cause of death.
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MODERATOR WILKINSON: Is there another question?
SPEAKER: I have heard that, in the initial stages of starvation, the blood
cholesterol level will often rise. I wonder if that is due to the fact that bile prob-
ably was not secreted and cholesterol was therefore retained. Is there any com-
ment on that?
MODERATOR WILKINSON: Dr. Keys wrote a two-volume book on starvation,
so I will give it to him.
DR. KEYS: It is not true. In the initial stages of starvation and in total fasting
the cholesterol level frequently rises. Our interpretation is that this is associated
with the mobilization and transport of lipid for metabolic purposes from the
body depots. So far as I know, it has no particular relation to the production,
secretion or reabsorption of bile. If you are going to live on the fat of your
own body, you still have to try to transport it around as lipid protein and you
have to do that by combining it with cholesterol. The liver will make all the
cholesterol you want, at any time, or even more than you want.
MODERATOR WILKINSON: Another question?
SPEAKER: I should like to ask Dr. Keys if there are any pathologic changes
in the blood vessels of people who are starving. If so, I presume that the lesion
would not be the usual atherosclerosis.
DR. KEYS: We have not carried our experiments that far, but we have had
the experience of examining material from concentration camps and others have
studied material from concentration and prisoner-of-war camps. There is complete
unanimity of opinion as to a striking absence of atherosclerosis or any other
abnormality that I know of in the blood vessels.
DR. KINSELL: Do you think this would speak for possible reversibility, as-
suming that a reasonable number of these people might have had atherosclerosis
before they got into the starving state?
DR. KEYS: I think, Dr. Kinsell, that that is the only reasonable interpretation
you can place upon this observation. We know that under normal circumstances
a sizable number of persons have atherosclerosis. The fact that these starved
people were uniformly found to be virtually free of atherosclerosis, suggests
either that all those who had atherosclerosis were the first ones to die in the
prisons, or that there had been some reversal.
DR. POLLAK: May I add one thing. Yesterday afternoon I talked to a pa-
thologist from Germany. He told me about necropsies on prisoners who came
from Russian camps. He remarked on the absence of atherosclerosis. Of course,
we do not all talk the same language. He added one comment. None of these
men had a body weight over 90 pounds.
MODERATOR WILKINSON: It looks as if we can be starved and have reasonable
assurance that we won't have atherosclerosis.
DR. KINSELL: May I say one word, Dr. Wilkinson, with regard to a previous
statement by Dr. Pollak to the effect that the same kind of variability in results
applies to the use of essential fatty acids as applies to the use of sitosterols. I
doubt that you meant this. If you did, perhaps you were misinformed. As far
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as we know, given a sufficient amount (which may vary with different persons
and may be very large) of essential fatty acid such as one of the high linoleic
acid-containing fats, any person can have his blood cholesterol level brought
within the normal range.
DR. POLLAK: I respect your opinion, but I read the literature and I know that
some people disagree with you.
DR. KINSELL: I mean in terms of our own experience over the past six years,
which includes controlled and semicontrolled studies in several hundred people.
MODERATOR WILKINSON: This is a matter of how much, not whether. Are
there any other questions from the floor?
SPEAKER: Do you have any diet, on the basis of present data, that you would
care to recommend to the practicing physician?
MODERATOR WILKINSON: We think that the heterozygous hyperlipemic
person is not uncommon, and that, if his fat intake is spaced so that he is able
to clear it before he has the next fat load, his blood lipid level can be kept within
a theoretically normal range. We also think that there is a real possibility that a
person may not be able to clear the fat load from the bloodstream as he grows
older. We, more or less arbitrarily, would advise people between 45 and 50
years of age to eat a fat-free breakfast, and anything they want for lunch and
dinner. Dr. Kinsell?
DR. KINSELL: We are using 3 diets at present. I think Dr. Wilkinson at this
meeting last year made a remark to the effect that there were 2 procedures for
lowering the blood cholesterol level. One was caponization by the administration
of estrogen and the other was the consumption of some of Kinsell's horrible diets.
He implied that he would prefer to have a coronary thrombosis and, in terms of
the formula diets and of caponization, we might be inclined to agree.
We have diets now which approach reasonable palatability. The composition
of these diets together with our observations will be published in the near future
in the Journal of the American Geriatrics Society.
MODERATOR WILKINSON: Dr. Keys, have you a diet?
DR. KEYS: The easiest way to get a diet of this sort is to go to some place
where the diet is specialized and developed for an entire population. That is why
I am sorry that I am not going to be in Italy this spring for the first time in
five years.
MODERATOR WILKINSON: Dr. Pollak, have you any diets?
DR. POLLAK: I have no suggestion to make. I agree with what has been said.
MODERATOR WILKINSON: Dr. Epstein?
DR. EpSTEIN: Even though the pathogenesis of the disease is very complex,
a cure may be relatively simple. If one could reduce the fat content of the diet
in this country, one might make an appreciable dent in the frequency of the
condition.
MODERATOR WILKINSON: That is Dr. Epstein's opinion.
SPEAKER: Nothing has been said about the soybean with reference to the
Oriental and his diet. I should like to be brought up to date on that.
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MODERATOR WILKINSON: The soybean products used in the Oriental diet
contain largely protein and practically no fat. The soy meal available to us
also contains little fat. I believe Dr. Keys will bear me out in this.
DR. KEYS: That is right; the consumption of soy oil is negligible in Japan.
The main form of eating soybeans is soy "curd," which is substantially a fat-free
protein.
SPEAKER: Should we recommend soybean for use in America?
DR. KEYS: Not I, after much experience trying to put this across as a war
measure in the feeding of soldiers.
SPEAKER: Can you say anything about lecithin and phospholipids in this
connection?
MODERATOR WILKINSON: The experience in our laboratory with lecithin has
been about the same as that with choline and methionine.
SPEAKER: I should like to ask whether or not any studies have been made
comparing any sizable group of vegetarians in this country with ordinary people
on ordinary diets?
MODERATOR WILKINSON: Dr. Keys?
DR. KEYS: There are not many true vegetarians. Dr. Stare has worked with
vegetarians in this country. I think most of them consume milk and milk prod-
ucts and otherwise are not proper vegetarians. There has been a study here in
the United States and another in the Netherlands, but I think they are not in
full agreement.
MODERATOR WILKINSON: There is quite a group in Southern California in a
Medical School-the College of Medical Evangelists. The whole principle of
the Seventh Day Adventists is vegetarianism, but it has been implied that there
are degrees of vegetarianism.
DR. KINSELL: I had a classmate in medical school who was a vegetarian,
but this meant only to the exclusion of rare beefsteak.
MODERATOR WILKINSON: Thank you.
